Advertisement

Topics

Thubrikar Aortic Valve, Inc. Company Profile

12:31 EDT 19th September 2018 | BioPortfolio

Thubrikar Aortic Valve, Inc., founded in October 2010, is a privately held medical device company headquartered in Norristown, PA. The Company has developed a low-profile, bovine pericardial, self-expanding percutaneous valve for transcatheter aortic valve implantation (TAVI) - called the “Optimum TAV” - as a treatment option for aortic stenosis. Optimum TAV was designed to mimic the natural aortic valve, improve durability, and to additionally be used in valve-in-valve procedures and bicuspid patients. The Company is also designing delivery systems for transfemoral, transapical, subclavian, and direct aortic access points. More information can be found at https://gust.com/c/thubrikar_aortic_valve.


News Articles [404 Associated News Articles listed on BioPortfolio]

Thubrikar and Labcor Strengthen Partnership with Nearly $1 Million Investment in Thubrikar

Thubrikar Aortic Valve, Inc., a privately held medical device company developing a next-generation Transcatheter Aortic Valve Implantation (TAVI) system, announced today the inves...

Researchers build molecular networks of calcific aortic valve disease

Calcific aortic valve disease - a disease that leaves the aortic valve stiff and calcified, preventing blood flow from the heart into the aorta - affects one quarter of the U.S. population aged 65 and...

Valve-in-Valve TAVR Matches 'Benchmark' of Native TAVR

Outcomes were similar or better compared with those of native-valve transcatheter aortic valve replacement, though longer follow-up will tell if it becomes the default strategy for most failed aortic ...

Self-Expanding Heart Valve Treats Severe Aortic Stenosis

A novel transcatheter heart valve (THV) valve aids treats patients with severe aortic stenosis requiring aortic valve replacement (AVR).

Rapid Deployment Valve for Aortic Stenosis Ups Stroke Risk

FRIDAY, April 13, 2018 -- For patients with aortic valve stenosis, treatment with a rapid deployment valve (RDV) is associated with increased rates of new-onset pacemaker implantation and disabling st...

LivaNova completes enrollment for global aortic valve replacement clinical trial

The company welcomed the recently updated interventional procedures guidance for sutureless aortic valve replacement issued by the U.K. National Institute for Health and Care Excellence (NICE), which ...

A molecular atlas of calcific aortic valve disease

(Brigham and Women's Hospital) A team of researchers from BWH has comprehensively analyzed gene expression and protein distribution in human aortic valves obtained from valve replacement surgery. Thei...

When Can Surgeons Perform Aortic Valve Replacement Safely After a Stroke?

Interrogation of Danish administrative registry data demonstrated that a stroke within three to four months of aortic valve surgery was associated with a higher rate of perioperative stroke.

PubMed Articles [1259 Associated PubMed Articles listed on BioPortfolio]

Aortic Valve-in-Valve in Externally Mounted Bioprosthesis: A Safe Treatment Option for Bioprosthetic Structural Valve Dysfunction.

Aortic valve-in-valve implantation for prosthetic valve dysfunction is a good alternative to reoperative valve replacement. There are some limitations to this approach including the risk of coronary o...

Transcaval Valve-in-Valve-in-Valve Aortic Valve Replacement for Bioprosthetic Valve Degeneration.

A 74-year-old man presented with progressive dyspnea on exertion. History included peripheral arterial disease and coronary artery bypass grafting with aortic valve replacement 12 years ago. Subsequen...

Meta-analysis of Valve-in-Valve Transcatheter versus Redo Surgical Aortic Valve Replacement.

 The objective of this study was to determine whether valve-in-valve transcatheter aortic valve implantation (VIV-TAVI) is associated with better survival than redo surgical aortic valve replacement...

Diagnostic significance of three-dimensional echocardiography in asymptomatic unicuspid aortic valve.

Unicuspid aortic valve (UAV) is a rare congenital anomaly of aorta associated with a faster progress of valvular dysfunction, aortic dilatation and with necessity for more frequent controls and precis...

Transcatheter Mitral Valve-In-Valve Dislocation: A Rescue Strategy.

In the TAVR (transcatheter aortic valve replacement) era, trans-apical valve-in-valve mitral valve implantation (TA-MVI) is considered an alternative treatment for high risk patients with degenerated ...

Clinical Trials [1106 Associated Clinical Trials listed on BioPortfolio]

Aortic Root Enlargement in Aortic Valve Replacement

Aortic valve disease is a progressive illness that varies from minor valve thickening lacking obstruction of blood stream to severe calcification and alteration of the valve leading to wea...

Minimally Invasive Aortic Valve Replacement Versus Conventional Aortic Valve Replacement. a Long Term Registry

The aim of the present study is to assess in a "real life" caselist the outcome of three different surgical approches for isolated aortic valve surgery in terms of surgery times, morbidity...

Transfemoral Replacement of Aortic Valve With HLT MeriDIAN Valve Feasibility Trial CANADA

To evaluate the safety and performance of the HLT System in patients with severe aortic stenosis who present at high risk for aortic valve replacement surgery.

Ascending Aortic Dilation in BiAV After TAVR

This study sought to evaluate changes in ascending aorta size after transcatheter aortic valve replacement (TAVR) in patients with bicuspid aortic valve (BiAV) compared with patients with ...

Clinical Investigation Of The Mitroflow Aortic Pericardial Heart Valve

This is a trial to demonstrate the safety and effectiveness of the Mitroflow Aortic Heart Valve when used to replace a diseased or dysfunctional aortic valve or aortic valve prosthesis.

Companies [80 Associated Companies listed on BioPortfolio]

Thubrikar Aortic Valve, Inc.

Thubrikar Aortic Valve, Inc., founded in October 2010, is a privately held medical device company headquartered in Norristown, PA. The Company has developed a low-profile, bovine ...

BioStable Science & Engineering, Inc.

BioStable Science & Engineering is a cardiovascular device company focused on developing and commercializing proprietary valve repair technologies that provide an alternative to v...

JC Medical, Inc.

JC Medical, Inc. is a private, venture-backed medical device company transforming the treatment of Aortic Valve Disease, a growing clinical need in the face of the prevalence of h...

JenaValve Technology, Inc.

JenaValve Technology, Inc., a U.S. corporation with primary operations in Munich, Germany, develops, manufactures and markets transcatheter aortic valve implantation systems (TAVI...

JenaValve Technology GmbH

JenaValve Technology is a medical device company focused on developing transcatheter-delivered aortic valve systems to treat patients suffering from aortic valve disease. The comp...

More Information about "Thubrikar Aortic Valve, Inc." on BioPortfolio

We have published hundreds of Thubrikar Aortic Valve, Inc. news stories on BioPortfolio along with dozens of Thubrikar Aortic Valve, Inc. Clinical Trials and PubMed Articles about Thubrikar Aortic Valve, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Thubrikar Aortic Valve, Inc. Companies in our database. You can also find out about relevant Thubrikar Aortic Valve, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...


Corporate Database Quicklinks



Searches Linking to this Company Record